Prevalence of overweight, central obesity and metabolic comorbidities risk in adults living with HIV/AIDS
DOI:
https://doi.org/10.5020/18061230.2016.p399Keywords:
Obesity, Anthropometry, Prevalence, HIV.Abstract
Objetive: To describe the prevalence of overweight, central obesity and risk of metabolic comorbidities in people living with HIV/AIDS, without antiretroviral (ARV) therapy. Methods: Observational, cross-sectional, descriptive study held in an Infectious and Parasitic Diseases Referral Treatment Center of Belo Horizonte, MG, with adults with HIV/AIDS, who had not initiated ARV therapy. The study collected information on weight, height, Body Mass Index (BMI) and waist circumference (WC). Food intake was investigated through the application of 24-hour dietary recall. Additionally, a questionnaire was used to collect socioeconomic data. Results: Of the 100 volunteers, 76% were men with average age of 37.1 years. Approximately one third had CD4 ≤ 200 and 64% were classified as sedentary. Men had higher mean weight (71.6 kg against 59.9 kg) and height (1.72m against 1.60m) compared to women. Weight excess and central obesity prevalences of were 4.1% and 35.7%, respectively. Substantially increased metabolic comorbidities risk was present in 20.4% of the subjects. Half of the sample consumed large amounts of processed foods and registered low consumption of fruits and vegetables. Conclusion: Before initiating the ARV therapy, the individuals with HIV/AIDS already presented overweight, central obesity, and consequent risk of metabolic comorbidities. Therefore, health education interventions prior to the ARV therapy are necessary for primary prevention of future metabolic problems.Downloads
References
UNAIDS. Global Report. Global AIDS Response Progress Reporting 2016. Geneva; 2016.
Ministério da Saúde (BR), Programa Nacional de DST e AIDS. Boletim epidemiológico: AIDS e DST 2015. Brasília: Secretaria de Vigilância em Saúde Brasília;2015.
Diaz CM, Segura ER, Luz PM, Clark JL, Ribeiro SR, De Boni R. Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIVinfected adults in Brazil: a retrospective cohort study. BMC Infect Dis. 2016; 16:376.
Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525-33.
Ribeiro SR, Luz PM, Campos DP, Moreira RI, Coelho L, Japiassu A, et al. Incidence and determinants of severe morbidity among HIV-infected patients from Rio de Janeiro, Brazil, 2000–2010. Antivir Ther. 2014;19(4):387–97.
Thapa R, Amatya A, Pahari DP, Bam K, Newman MS. Nutritional status and its association with quality of life among people living with HIV attending public anti-retroviral therapy sites of Kathmandu Valley, Nepal. AIDS Res Ther. 2015;12:14.
Srinivasa S, Grinspoon SK. Metabolic and body composition effects of newer antiretrovirals in HIVinfected patients. Eur J Endocrinol. 2014;170(5):185-202.
Deeks SG. HIV Infection, Inflammation, Immunosenescence, and Aging. Annu Rev Med 2011;62:141–155.
Signorini DJ, Monteiro MC, Andrade MF, Signorini DH, Eyer-Silva WA.What should we know about metabolic syndrome and lipodystrophy in AIDS? Rev Assoc Med Bras 2012;58(1):70-5.
Núñez-Rocha GM, Wall KM, Chávez-Peralta M, Salinas-Martínez AM, Benavides-Torres RA. Nutritional care, time period since diagnosis, demographics and body mass index in HIV/AIDS patients. Rev Invest Clin. 2013;65(4):291-9.
Wang ZM, Pierson RN Jr, Heymsfield SB. The five live method: a new approach to organizing body composition research. Am J Clin Nutr. 1992;56(1):19-28.
Taylor BS, Liang Y, Garduño LS, Walter EA, Gerardi MB, Anstead GM, et al. High risk of obesity and weightgain for HIV-infected uninsured minorities. J Acquir Immune Defic Syndr. 2014;65(2):33-40.
Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013;309(1):71–82.
Jaime PC, Florindo AA, Latorre MRDO, Brasil BG, Santos ECM, Segurado AAC. Prevalência de sobrepeso e obesidade abdominal em indivíduos portadores de HIV/AIDS, em uso de terapia antirretroviral de alta potência. Rev Bras Epidemiol. 2004;7(1):65-72.
World Health Organization. Physical status: the use and interpretation of anthropometry. Geneva: WHO; 1995. (WHO Technical Report Series, 854).
World Health Organization. Waist Circumference and Waist-Hip Ratio. Geneva: WHO; 2008. (Report of a WHO Expert Consultation).
Monteiro JP, Pfrimer K, Tremeschin MH. Nutrição e metabolismo: consumo alimentar – visualizando porções. Rio de Janeiro: Guanabara Koogan; 2007.
Reinstem CSB. Diet Win Clínico. Software Avaliação Nutricional. Versão 2.1.8. Rio Grande do Sul; 2008.
Phillipi ST. Tabela de composição de alimentos: suporte para decisão nutricional. 2ª ed. São Paulo: Coronário; 2002.
Ministério da Saúde (BR). Guia Alimentar da população Brasileira [Internet]. Brasília: Ministério da Saúde; 2014 [acesso em 2016 Set 10]. Disponível em:http://portalsaude.saude.gov.br/images/pdf/2014/ novembro/05/Guia-Alimentar-para-a-pop-brasiliera- Miolo-PDF-Internet.pdf
Leite LHM, Sampaio ABDMM. Progression to overweight, obesity and associeted factors after antiretroviral therapy initiation among Brazilian persons with HIV/AIDS. Nutr Hosp. 2010;25(4):635-40.
Freitas P, Carvalho D, Santos AC, Madureira AJ, Martinez E, Pereira J, et al. Carotid intima media thickness is associated with body fat abnormalities in HIV-infected patients. BMC Infect Dis. 2014;14(348):1-9.
Koethe JR, Jenkins CA,Lau B. Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada. AIDS Res Hum Retroviruses. 2016;32(1):50-8.
Instituto Brasileiro de Geografia e Estatística - IBGE. Pesquisa de orçamento familiares, 2008- 2009 [acesso em 2016 Set 20]. Disponível em:http://www.ibge.gov.br/home/estatistica/populacao/ condicaodevida/pof/2008_2009_analise_consumo/pofanalise_2008_2009.pdf
Jaime PC, Florindo AA, Latorre MRDO, Segurado AAC. Central obesity and dietary intake in HIV/AIDS patients. Rev Saúde Pública. 2006;40(4):634-40.
